In silico clinical trial evaluating lisdexamfetamine’s and methylphenidate’s mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients’ population
IntroductionAttention-deficit/hyperactivity disorder (ADHD) is an impairing psychiatric condition with the stimulants, lisdexamfetamine (LDX), and methylphenidate (MPH), as the first lines pharmacological treatment.MethodsHerein, we applied a novel in silico method to evaluate virtual LDX (vLDX) and...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2023-06-01
|
| Col·lecció: | Frontiers in Psychiatry |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.939650/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|